ARM Outlines Data-Reuse Playbook For Gene Editing, Aiming To Cut Rare-Disease Development Work
The Catalyst Brief
Coverage
Regulatory & Policy
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.
Latest
Nancy Krieger Warns Census Changes Could Weaken Public Health Data And Federal Resource Targeting
The Catalyst Brief
Betsy Pleasants Uses Reddit NLP To Track Abortion Access Barriers, Extending Real-Time Public Health Surveillance
The Catalyst Brief
Trump Administration Investigates 9 Universities For Alleged J-1 Visa Fraud, Pressuring Biomedical Research Staffing
The Catalyst Brief
Most read
ARPA-H Launches SURPASS To Speed Clinical Trials With AI Models, As HHS Pushes Fewer Participants And Lower Costs
The Catalyst Brief
NIH Unveils Eight-Hub Website Redesign, Replacing A 700-Plus Site Structure
The Catalyst Brief
NIH Awarded Roughly $34 Billion In FY2026 Grants, But Funded About 58,000 Projects After Delays
The Catalyst Brief
Fresenius Kabi Receives FDA Warning Letter After Famotidine Adverse-Event Investigation, Melrose Park Site Stays Open
The Catalyst Brief
More in this beat
Oct 8, 2026FDA Extends Mifepristone Safety Review Into 2027, Leaving U.S. Access Fight Unresolved
The filing is the first substantive public update on the reevaluation ordered by Health Secretary Robert F. Kennedy Jr. The agency said it is using a statistical data mining method to look for unknown safety concerns and is also considering petitions that seek changes to how the drug is prescribed and distributed.
The Catalyst Brief
Oct 8, 2026Trump Administration Proposes $70,000 OPT Fee, Raising Pressure On International STEM Training
The Department of Homeland Security said the fee would help combat alleged fraud and abuse in Optional Practical Training and help U.S. citizens compete against international applicants in the job market. Critics argue the proposal adds another layer of uncertainty to a system that many science trainees use as a bridge to longer-term work in the U.S.
The Catalyst Brief
Oct 7, 2026FTC Sends Warning Letters To 24 Healthcare Organizations Over Price Transparency, Expanding Pressure Beyond CMS Rules
The FTC did not name the recipients and said the letters do not conclude that the organizations violated the FTC Act. But the agency drew a clear distinction between existing CMS hospital transparency rules and its own view that incomplete or inaccurate pricing disclosures can still mislead consumers.
The Catalyst Brief
Oct 6, 2026Novo’s Denecimig Review Slips After FDA Flags Manufacturing Remediation
Novo said the FDA needs more time to review denecimig because of remediation work at an unnamed manufacturing site. The episode shows how manufacturing execution can still reset timelines for late-stage assets even when the agency has not raised efficacy or safety concerns.
The Catalyst Brief
Oct 6, 2026UK Backs Continuous Monitoring For AI Medical Devices, Replacing A One-Time Review Model
A new set of 44 recommendations accepted by the U.K. government would reshape oversight of AI-enabled medical devices. For developers, the change signals tighter post-market accountability, but also an attempt to build a more agile route for products whose performance and risks can evolve after launch.
The Catalyst Brief
Oct 6, 2026Stem Cell Advocates Seek FDA Roundtables As Peptide Policy Opens A New Regulatory Push
At PepMed 2026, regenerative medicine advocates linked peptides and stem cells as part of the same policy opening. Their argument is less about new clinical evidence than about whether the current regulatory mood could create a path for broader acceptance of unapproved stem cell therapies.
The Catalyst Brief
Trump Announces $90 Medicare Premium Payments For More Than 20 Million Seniors, Days Before Midterms
The White House said Medicare Part B enrollees will receive the payments in October through direct deposit or check. Eligibility excludes people already getting premium assistance from Medicaid, those paying adjusted monthly premiums based on income, and seniors enrolled in Medicare Advantage.
The Catalyst Brief
Oct 4, 2026Pennsylvania Reports 943 Measles Cases And Fifth Death, As Officials Face An Unknowable Outbreak Size
A fifth measles death in Pennsylvania has put attention on a basic surveillance problem: confirmed case counts capture only part of an outbreak. The reporting points to structural blind spots in counties with large Amish populations, where low vaccination rates, large families, and delayed care-seeking can keep infections out of official tallies.
The Catalyst Brief
Oct 3, 2026NIH Awarded Roughly $34 Billion In FY2026 Grants, But Funded About 58,000 Projects After Delays
The National Institutes of Health awarded roughly $34 billion in external grants in the 2026 fiscal year, which ended Wednesday, after another slow start. But according to a STAT analysis, the agency funded around 58,000 projects, reduced awards involving health disparities, race, and ethnicity, and left researchers describing a review process that slowed their work and complicated plans for innovative science.
The Catalyst Brief
Oct 3, 2026NIH Unveils Eight-Hub Website Redesign, Replacing A 700-Plus Site Structure
The new NIH site, set to be unveiled on Monday after a beta soft launch this week, is built around health, research, data, clinical studies, rare diseases, technology, cancer, and grants. Agency officials say the goal is to make trusted information easier to find while consolidating a fragmented digital footprint of more than 700 separate websites.
The Catalyst Brief
Oct 3, 2026Congo Ebola Outbreak Passes 4,018 Deaths As Burned Treatment Site Cuts Response Capacity
Authorities and aid groups are trying to contain what officials described as the fastest-growing Ebola outbreak in history while resources remain limited and community mistrust persists. The latest setbacks show that outbreak control depends not only on diagnostics and treatment capacity, but also on worker pay, security, and local cooperation.
The Catalyst Brief
Oct 3, 2026Youth Opioid Treatment Study Finds 1 In 32 Stay On Medication For Six Months Despite Better Access
Researchers reviewed claims for people ages 13 to 25 diagnosed with opioid use disorder between 2016 and 2023. The results point to a gap between initial access and continuity of care, with legal restrictions, limited youth-specific treatment settings, family concerns, and racial disparities all contributing to attrition.
The Catalyst Brief
Other beats
AI in Drug Discovery
Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Biopharmaceutical Industry
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Biotech Innovation
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Healthcare Investment
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
Medical Technology
Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.